230 related articles for article (PubMed ID: 33045182)
21. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection.
Montes-Carmona JF; Gonzalez-Perez LM; Infante-Cossio P
Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374687
[TBL] [Abstract][Full Text] [Related]
22. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
Porta M
Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
[TBL] [Abstract][Full Text] [Related]
23. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
Ojala T; Arokoski JP; Partanen J
Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
[TBL] [Abstract][Full Text] [Related]
25. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
26. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain.
Miotto E; Salvatore Freitas KM; Mori AA; Valarelli FP; Gobbi de Oliveira RC; Oliveira RC
Pain Manag; 2021 Sep; 11(5):583-593. PubMed ID: 33980033
[No Abstract] [Full Text] [Related]
27. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
28. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
J Headache Pain; 2016; 17():29. PubMed ID: 27011213
[TBL] [Abstract][Full Text] [Related]
29. Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.
Nitecka-Buchta A; Walczynska-Dragon K; Batko-Kapustecka J; Wieckiewicz M
Pain Res Manag; 2018; 2018():8261090. PubMed ID: 29973970
[TBL] [Abstract][Full Text] [Related]
30. Safety and Efficacy of PrabotulinumtoxinA (Nabota
Kim DY; Kim JM
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
[TBL] [Abstract][Full Text] [Related]
31. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
Thomas NJ; Aronovich S
J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
[TBL] [Abstract][Full Text] [Related]
32. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.
Villa S; Raoul G; Machuron F; Ferri J; Nicot R
J Stomatol Oral Maxillofac Surg; 2019 Feb; 120(1):2-6. PubMed ID: 30385428
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
Dessie SG; Von Bargen E; Hacker MR; Haviland MJ; Elkadry E
Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
[TBL] [Abstract][Full Text] [Related]
34. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
[TBL] [Abstract][Full Text] [Related]
36. Platelet-Rich Plasma Intramuscular Injections - Antinociceptive Therapy in Myofascial Pain Within Masseter Muscles in Temporomandibular Disorders Patients: A Pilot Study.
Nitecka-Buchta A; Walczynska-Dragon K; Kempa WM; Baron S
Front Neurol; 2019; 10():250. PubMed ID: 30941095
[No Abstract] [Full Text] [Related]
37. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
Desai MJ; Shkolnikova T; Nava A; Inwald D
Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
Nicol AL; Wu II; Ferrante FM
Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial.
De la Torre Canales G; Poluha RL; Bonjardim LR; Ernberg M; Conti PCR
Sci Rep; 2024 Feb; 14(1):4201. PubMed ID: 38378855
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
Wheeler AH; Goolkasian P; Gretz SS
Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
